Battelle Memorial Institute Contract Details

Defense contract under the Defense Advanced Research Projects Agency awarded to Battelle Memorial Institute on 8/15/2014.

Per the U.S. DoD, * Indicates a "small business" classification and ** indicates a "small disadvantaged business". NOTE: the U.S. DoD only publicly reports contracts valued at $6.5 million USD or greater.

The contract language is EXACTLY as it appears on the official U.S. DoD website ( unless otherwise noted.

Contractor: Battelle Memorial Institute
Department: Defense Advanced Research Projects Agency
Awarded: 8/15/2014

Battelle Memorial Institute, Columbus, Ohio, has been awarded a $6,577,033 modification (P00013), exercising the second option to an eight-month base contract (HR0011-13-C-0023) and a 21-month Phase 2/Option 1. The second option serves as Phase 3 to the Dialysis-Like Therapeutics (DLT) Integration program. This is a cost-plus-fixed-fee contract. Exercise of the option brings the total cumulative face value of the contract to $15,555,013 from $8,977,980. Work will be performed in Columbus, Ohio, with an expected completion date of Jan. 29, 2016 (end date of Phase 3). Fiscal 2014 research, development, test and evaluation funds in the amount of $3,092,251 are being obligated at time of award. The Defense Advanced Research Projects Agency (DARPA), Arlington, Virginia, is the contracting activity.

Total Contract Value: $6,577,033

View all contracts that include "Battelle Memorial Institute" in the MiC database.